ConductScience.org, home

Paper41346243

Inhibition of calreticulin by protein nanoparticles carrying antisense oligonucleotides reduce gene expression and infection of Trypanosoma cruzi trypomastigotes on mammalian cells.

Prestegui-Martel B and 6 others. Nanomedicine (Lond), 2025. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Inhibition of calreticulin by protein nanoparticles carrying antisense oligonucleotides reduce gene expression and infection of Trypanosoma cruzi trypomastigotes on mammalian cells. Papers, record 41346243. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41346243

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Inhibition of calreticulin by protein nanoparticles carrying antisense oligonucleotides reduce gene expression and infection of Trypanosoma cruzi trypomastigotes on mammalian cells.
PubMed
Journal
Nanomedicine (Lond)
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-03-16
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Prestegui-Martel BB
2Martínez II
3Cárdenas-Guerra RER E
4Cortés-Coss AKA K
5Del Toro-Ríos XX
6Hernández-Garcia AA
7Espinoza BB

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Trypanosoma cruziMajor topic
Oligonucleotides, AntisenseMajor topic
CalreticulinMajor topic
NanoparticlesMajor topic
Chagas DiseaseMajor topic
Animals
Humans
Protozoan Proteins

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
SECIHTIPubMed
UNAM-PAPIITPubMed

Source PubMed

Download CSV of grants

References45

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132356888Phosphorothioate modified oligonucleotide-protein interactions.Nucleic Acids Res2020https://conductscience.org/library/papers/32356888PubMed
215385491A new cruzipain-mediated pathway of human cell invasion by Trypanosoma cruzi requires trypomastigote membranes.Infect Immun2004https://conductscience.org/library/papers/15385491PubMed
324551259A monoallelic deletion of the TcCRT gene increases the attenuation of a cultured Trypanosoma cruzi strain, protecting against an in vivo virulent challenge.PLoS Negl Trop Dis2014https://conductscience.org/library/papers/24551259PubMed
418657458Calcineurin B of the human protozoan parasite Trypanosoma cruzi is involved in cell invasion.Microbes Infect2008https://conductscience.org/library/papers/18657458PubMed
529367754Mitochondrial biogenesis and metabolic hyperactivation limits the application of MTT assay in the estimation of radiation induced growth inhibition.Sci Rep2018https://conductscience.org/library/papers/29367754PubMed
610233151Trypanosoma cruzi calreticulin is a lectin that binds monoglucosylated oligosaccharides but not protein moieties of glycoproteins.Mol Biol Cell1999https://conductscience.org/library/papers/10233151PubMed
733633318Antisense oligonucleotide development for the selective modulation of CYP3A5 in renal disease.Sci Rep2021https://conductscience.org/library/papers/33633318PubMed
833006041Differential gene expression of virulence factors modulates infectivity of TcI Trypanosoma cruzi strains.Parasitol Res2020https://conductscience.org/library/papers/33006041PubMed
920472323Trypanosoma cruzi calreticulin: a novel virulence factor that binds complement C1 on the parasite surface and promotes infectivity.Immunobiology2011https://conductscience.org/library/papers/20472323PubMed
1031437457The effects of endoplasmic reticulum stressors, tunicamycin and dithiothreitol on Trypanosoma cruzi.Exp Cell Res2019https://conductscience.org/library/papers/31437457PubMed
1135327448Calreticulin Regulates β1-Integrin mRNA Stability in PC-3 Prostate Cancer Cells.Biomedicines2022https://conductscience.org/library/papers/35327448PubMed
1222954747Trypanosoma cruzi carrying a monoallelic deletion of the calreticulin (TcCRT) gene are susceptible to complement mediated killing and defective in their metacyclogenesis.Mol Immunol2013https://conductscience.org/library/papers/22954747PubMed
1325150720Design and self-assembly of simple coat proteins for artificial viruses.Nat Nanotechnol2014https://conductscience.org/library/papers/25150720PubMed
1430131175Variable numbers of calreticulin genes in Trypanosoma cruzi correlate with atypical morphology and protein expression.Immunobiology2018https://conductscience.org/library/papers/30131175PubMed
1530831156Proteomic analysis of glycosomes from Trypanosoma cruzi epimastigotes.Mol Biochem Parasitol2019https://conductscience.org/library/papers/30831156PubMed
1628437166Virus-Like Particles of mRNA with Artificial Minimal Coat Proteins: Particle Formation, Stability, and Transfection Efficiency.Nucleic Acid Ther2017https://conductscience.org/library/papers/28437166PubMed
1722808206Thrombospondin-1 interacts with Trypanosoma cruzi surface calreticulin to enhance cellular infection.PLoS One2012https://conductscience.org/library/papers/22808206PubMed
1818512343Trypanosoma cruzi: parasite and host cell signaling during the invasion process.Subcell Biochem2008https://conductscience.org/library/papers/18512343PubMed
1935271563Characteristics and Adverse Events of Patients for Whom Nifurtimox Was Released Through CDC-Sponsored Investigational New Drug Program for Treatment of Chagas Disease - United States, 2001-2021.MMWR Morb Mortal Wkly Rep2022https://conductscience.org/library/papers/35271563PubMed
2032896515Optimization and application of MTT assay in determining density of suspension cells.Anal Biochem2020https://conductscience.org/library/papers/32896515PubMed

See all 45 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41346243

GET https://conductscience.org/api/papers/v1/41346243/references?page=2